Tregs derived from ITP patients displayed distinct molecular and functional signatures compared to normal controls, with dynamic alterations in key markers such as ANXA1, FOXP3, and CCR6 during disease progression. Here, ANXA1 is linked to autoimmune thrombocytopenic purpura.